Biotech

All Articles

A nearer examine Ferocious Biotech's Brutal 15

.Within this full week's episode of "The Best Pipe," we are actually diving right into Intense Biote...

Lilly faces stage 2 failure of tau-targeting med

.The confetti is actually still flying from Eli Lilly's event celebrating the commendation of Alzhei...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of substantial leadership hirings, firings an...

Lykos will definitely talk to FDA to reevaluate its own selection following being rejected of MDMA therapy for trauma

.Complying with a bad revealing for Lykos Therapies' MDMA prospect for trauma at a recent FDA adviso...

AN 2 one-halfs headcount, ceases stage 3 test after data let down

.AN2 Therapies is actually rethinking its organization in action to lackluster midphase information,...

Merck pays out $700M for bispecific, spying autoimmune opening and odds to test Amgen in cancer

.Merck &amp Co. is paying for $700 million in advance to test Amgen in a blood cancer market. The of...

Gilead pays for J&ampJ $320M to leave licensing offer for seladelpar

.Along With Gilead Sciences almost an FDA choice for its liver illness medication seladelpar, the pr...

' All hands on deck' at Lilly as peers target obesity market

.Chief executive officer David Ricks can easily see the business establishing tents at basecamp resp...

Entero giving up personnel, abandoning workplace and also stopping briefly R&ampD

.Cushion Liquidators has transformed Entero Therapeutics white colored as a slab. The financial inst...

Exelixis drops ADC after deciding it is actually no match for Tivdak

.Exelixis is quiting on its own tissue factor (TF)- targeting antibody-drug conjugate after ending t...